Partnership in early drug development
May 10, 2012
Ensuring that studies and publications address clinically important questions, making public all results in a timely manner, and practicing zero tolerance towards selective or biased disclosure of research results are among the steps that will help to restore the credibility of industry-sponsored clinical research, says the multi-stakeholder Medical Publishing Insights and Practices (MPIP) Initiative.
Full story